Indore: Mumbai-based Hariva Meditech Private Limited has proposed a Rs 200 crore investment to set up a manufacturing unit for critical care and medical technology products at the Ujjain medical devices park. It has planned to produce continuous blood glucose monitoring systems, vacuum-assisted wound closure systems, consumables and anaesthesia products.
The company has sought around 20 acres of land for the project which is expected to generate employment for about 650 people. The proposal has been examined by the committee, which has given an in-principle go-ahead for land allotment.
Eight medical device units are also lined up to begin operations during the current financial year at the park, manufacturing products such as catheters, syringes, diagnostic kits, implants and blood collection devices. These units are expected to bring in investment of around Rs 254 crore and generate employment for nearly 2,400 people.
MPIDC executive director Rajesh Rathod said, “Apart from new proposals like Hariva Meditech, several companies that have already been allotted land are in advanced stages of setting up their facilities. A number of these units are expected to go on stream within this financial year, which will translate into actual production and employment on the ground.”
CliniSupplies India Pvt Ltd will produce catheters and related devices, VRM Molecular and Nuclear Medicines Pvt Ltd will focus on specialised medical formulations, HC Lifeline will manufacture syringes and cannula, and KRM Healthcare will produce diagnostic kits. Microgen Healthcare will make infection control products, wound care and orthopaedic implants, Maple Technologies will focus on women’s healthcare devices, Shreeji Polymers Medical Devices will produce insulin devices and spray pumps while Bioline India will manufacture blood collection and blood bag products.
